www.精品-www.激情五月-www.波多野结衣.com-www.波多野-高清国产视频

證券日報微信

證券日報微博

您所在的位置: 網(wǎng)站首頁 > 公司產(chǎn)業(yè) > 公告快訊 > 正文

三鑫醫(yī)療:公司正穩(wěn)步推進濕膜透析器在各地區(qū)的市場準入和入院工作

2025-08-13 19:27  來源:證券日報網(wǎng) 

    證券日報網(wǎng)訊 ?三鑫醫(yī)療8月13日發(fā)布公告,在公司回答調(diào)研者提問時表示,公司自主研發(fā)并作為國產(chǎn)品牌首次獲得審批注冊的一次性使用血液透析器(濕膜,高通量/非高通量),作為普通透析器迭代升級產(chǎn)品服務(wù)于廣大透析患者,其以先進的透析膜濕化填充工藝和更加優(yōu)異的生物相容性,減少了過敏反應,提升了患者的透析體驗和生存質(zhì)量,該產(chǎn)品與PP、PC材質(zhì)高通量、非高通量“干膜”透析器,共同構(gòu)成國產(chǎn)品牌血液透析器最齊全的產(chǎn)品群。公司正穩(wěn)步推進濕膜透析器在各地區(qū)的市場準入和入院工作,全力做好與醫(yī)保的配合、與集采政策的銜接,通過差異化的競爭策略提升血液透析器的市場份額,不斷擴大濕膜透析器的臨床應用。

(編輯 王雪兒)

-證券日報網(wǎng)

版權(quán)所有《證券日報》社有限責任公司

互聯(lián)網(wǎng)新聞信息服務(wù)許可證 10120240020增值電信業(yè)務(wù)經(jīng)營許可證 京B2-20250455

京公網(wǎng)安備 11010602201377號京ICP備19002521號

證券日報網(wǎng)所載文章、數(shù)據(jù)僅供參考,使用前務(wù)請仔細閱讀法律申明,風險自負。

證券日報社電話:010-83251700網(wǎng)站電話:010-83251800

網(wǎng)站傳真:010-83251801電子郵件:xmtzx@zqrb.net

官方客戶端

安卓

IOS

官方微信

掃一掃,加關(guān)注

官方微博

掃一掃,加關(guān)注

主站蜘蛛池模板: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |